- Home
- TECH vs EXLS Comparison
TECH vs EXLS Comparison
Compare TECH & EXLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TECH
- EXLS
- Stock Information
- Founded
- TECH 1976
- EXLS 1999
- Country
- TECH United States
- EXLS United States
- Employees
- TECH N/A
- EXLS N/A
- Industry
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- EXLS Business Services
- Sector
- TECH Health Care
- EXLS Consumer Discretionary
- Exchange
- TECH Nasdaq
- EXLS Nasdaq
- Market Cap
- TECH 7.8B
- EXLS 7.0B
- IPO Year
- TECH 1989
- EXLS 2006
- Fundamental
- Price
- TECH $49.15
- EXLS $46.07
- Analyst Decision
- TECH Buy
- EXLS Strong Buy
- Analyst Count
- TECH 10
- EXLS 7
- Target Price
- TECH $73.44
- EXLS $50.29
- AVG Volume (30 Days)
- TECH 2.3M
- EXLS 1.6M
- Earning Date
- TECH 05-07-2025
- EXLS 04-29-2025
- Dividend Yield
- TECH 0.65%
- EXLS N/A
- EPS Growth
- TECH N/A
- EXLS 21.21
- EPS
- TECH 0.83
- EXLS 1.32
- Revenue
- TECH $1,208,770,000.00
- EXLS $1,902,884,000.00
- Revenue This Year
- TECH $8.19
- EXLS $14.18
- Revenue Next Year
- TECH $8.61
- EXLS $11.43
- P/E Ratio
- TECH $59.07
- EXLS $34.88
- Revenue Growth
- TECH 4.72
- EXLS 14.18
- 52 Week Low
- TECH $46.44
- EXLS $28.59
- 52 Week High
- TECH $85.57
- EXLS $52.43
- Technical
- Relative Strength Index (RSI)
- TECH 44.74
- EXLS 50.90
- Support Level
- TECH $46.35
- EXLS $45.31
- Resistance Level
- TECH $54.40
- EXLS $48.16
- Average True Range (ATR)
- TECH 2.17
- EXLS 1.50
- MACD
- TECH 0.27
- EXLS 0.05
- Stochastic Oscillator
- TECH 34.78
- EXLS 45.82
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
About EXLS ExlService Holdings Inc.
ExlService Holdings Inc. is a business process management company that provides digital operations and analytical services to clients driving enterprise-scale business transformation initiatives that leverage the company's deep expertise in analytics, AI, ML, and cloud. The company offers business process outsourcing and automation services, and data-driven insights to customers across multiple industries. The company operates through four segments based on the products and services offered and markets served: Insurance, Healthcare, Emerging Business, and Analytics . The vast majority of the company's revenue is earned in the United States, and more than half of its revenue comes from Analytics segment.